{"gene":"CIZ1","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":1999,"finding":"CIZ1 (Ciz1) binds directly to the N-terminal, CDK2-interacting part of p21(Cip1/Waf1) through a region of ~150 amino acids containing its first zinc-finger motif; this interaction is disrupted by overexpression of CDK2. Coexpression of Ciz1 with p21 induces cytoplasmic redistribution of p21, showing Ciz1 regulates p21 subcellular localization.","method":"Yeast two-hybrid, co-immunoprecipitation, immunofluorescence, overexpression in U2-OS cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal binding mapped to specific domain, functional localization consequence shown, single lab with two orthogonal methods","pmids":["10529385"],"is_preprint":false},{"year":2003,"finding":"CIZ1 binds DNA directly and recognizes the consensus sequence ARYSR(0-2)YYAC, as determined by a modified SAAB (selected and amplified binding) method and confirmed by electrophoretic mobility shift assays. CIZ1 localizes to the nucleus in a broad range of tissues.","method":"SAAB sequence selection, EMSA, immunofluorescence, Northern blot","journal":"Journal of biomedical science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — DNA-binding consensus established by SAAB and validated by EMSA, single lab, two orthogonal methods","pmids":["12824700"],"is_preprint":false},{"year":2004,"finding":"Ciz1 promotes initiation of mammalian DNA replication: recombinant Ciz1 increases the number of nuclei initiating DNA replication in a cell-free reconstitution system; GFP-Ciz1 stimulates DNA synthesis in intact cells; mutation of putative CDK phosphorylation sites at threonines 191/192 alters Ciz1 activity in vitro. Endogenous Ciz1 localizes to nuclear foci co-localizing with PCNA during S phase, and RNAi depletion of Ciz1 inhibits S-phase entry with accumulation of chromatin-bound Mcm3 and PCNA but failure to synthesize DNA.","method":"Cell-free DNA replication reconstitution assay, GFP overexpression in intact cells, site-directed mutagenesis, immunofluorescence co-localization with PCNA, RNAi knockdown with flow cytometry and BrdU incorporation","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Strong — cell-free reconstitution with recombinant protein, mutagenesis of functional sites, and multiple cellular assays in a single study","pmids":["15585571"],"is_preprint":false},{"year":2006,"finding":"Ciz1 functions as a coactivator of estrogen receptor alpha (ERα): Ciz1 protein binds directly to ERα-associated chromatin, enhances ER transactivation activity, and promotes recruitment of the ER complex to target gene chromatin. Ciz1 overexpression confers estrogen hypersensitivity and promotes anchorage-independent growth and tumorigenicity in breast cancer cells.","method":"Chromatin immunoprecipitation (ChIP), reporter transactivation assay, proliferation and colony formation assays, xenograft","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrates chromatin recruitment and transactivation assay shows functional consequence; single lab, two orthogonal methods","pmids":["17108141"],"is_preprint":false},{"year":2007,"finding":"CIZ1 is immobilized at the nuclear matrix through sequences in its C-terminal third (amino acids 708–830), in a cell-cycle-dependent manner coinciding with late G1/early S phase. Matrix-associated CIZ1 foci co-localize with sites of newly synthesized DNA (replication factories). N-terminal domains are additionally required to specify focal organization, while C-terminal domains alone are sufficient for nuclear matrix immobilization.","method":"GFP-tagged fragment analysis, nuclease and high-salt extraction (nuclear matrix fractionation), immunofluorescence co-localization with BrdU-labeled replication sites","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain mapping by deletion analysis combined with nuclear matrix fractionation and direct co-localization with replication sites; multiple orthogonal methods in one study","pmids":["17182902"],"is_preprint":false},{"year":2007,"finding":"Ciz1 interacts with ERH (enhancer of rudimentary homolog) through residues 531–644 encompassing its first zinc finger motif; this region overlaps the p21(Cip1/Waf1)-binding site, suggesting competitive binding. When coexpressed, Ciz1 recruits ERH to DNA replication foci in HeLa cells.","method":"Yeast two-hybrid, GST pull-down assay, tandem MS, immunofluorescence co-localization","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GST pull-down and yeast two-hybrid plus MS identification; functional recruitment shown by co-localization; single lab","pmids":["18081865"],"is_preprint":false},{"year":2007,"finding":"A cancer-associated alternatively spliced CIZ1 variant lacking exon 4 (ΔE4) retains replication activity but fails to form subnuclear foci. Coexpression of mouse ΔE4 with wild-type Ciz1 prevents normal Ciz1 focal localization, exerting a dominant-negative effect on foci formation. Exon 4 skipping is caused by expansion of an intronic mononucleotide repeat in Ewing tumor cell lines.","method":"Exon-trap splicing assay, immunofluorescence, dominant-negative coexpression experiment, sequencing","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays (splicing and dominant-negative localization) combined with molecular characterization; single lab, two orthogonal methods","pmids":["17508423"],"is_preprint":false},{"year":2008,"finding":"A CIZ1 isoform lacking the glutamine-rich region encoded by exon 8 (due to alternative splicing) loses the ability to associate with the nuclear matrix and form nuclear foci; a minimal 28 amino acid sequence within this glutamine-rich region is required for nuclear matrix association and foci formation.","method":"Immunofluorescence, nuclear matrix fractionation, domain deletion analysis in transfected cells","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain identified by deletion analysis with functional nuclear matrix fractionation readout; single lab","pmids":["18583151"],"is_preprint":false},{"year":2010,"finding":"Ciz1 interacts with cyclin E and cyclin A sequentially through distinct cyclin-binding motifs; cyclin A displaces cyclin E from Ciz1. In cell-free assays, recombinant cyclin-A-CDK2 and recombinant Ciz1 cooperate to promote initiation of DNA replication in late G1-phase nuclei. Ciz1 immobilizes cyclin A in isolated nuclei and RNAi depletion of Ciz1 impairs cyclin A nuclear immobilization, indicating Ciz1 targets cyclin-A kinase to specific subnuclear sites.","method":"Cell-free DNA replication reconstitution assay with recombinant proteins, co-immunoprecipitation (cyclin E/A displacement), RNAi knockdown with immunofluorescence for cyclin A localization","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Strong — cell-free reconstitution with recombinant proteins, domain-mapped sequential cyclin interactions, and RNAi functional validation; multiple orthogonal methods","pmids":["20215406"],"is_preprint":false},{"year":2012,"finding":"A missense mutation in CIZ1 (c.790A>G, p.S264G), identified as causal for adult-onset primary cervical dystonia, alters CIZ1 splicing patterns (demonstrated by minigene assay) and alters the nuclear localization of CIZ1.","method":"Exome sequencing, minigene splicing assay, immunofluorescence for nuclear localization","journal":"Annals of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — minigene assay directly demonstrates splice alteration and localization change shown; single lab, two methods","pmids":["22447717"],"is_preprint":false},{"year":2012,"finding":"In non-proliferating spermatocytes, CIZ1 interacts with germ-cell-specific cyclin A1 (distinct from somatic cyclin A2). Antibody depletion of CIZ1 from testis extract reduces the capacity to repair digested plasmid DNA in vitro, suggesting a post-replicative role for CIZ1 in DNA double-strand break repair in germ cells.","method":"Co-immunoprecipitation (CIZ1–cyclin A1), in vitro plasmid repair assay with antibody depletion","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP identifies binding partner and in vitro depletion assay demonstrates functional consequence; single lab, two methods","pmids":["22366453"],"is_preprint":false},{"year":2013,"finding":"CIZ1-null MEFs are sensitive to hydroxyurea-induced replication stress and susceptible to oncogene-induced cellular transformation; Ciz1-null mice developed various leukemias in a retroviral insertional mutagenesis model, establishing CIZ1 as a tumor suppressor in vivo.","method":"Knockout mouse model, hydroxyurea sensitivity assay, oncogene transformation assay in MEFs, retroviral insertional mutagenesis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple orthogonal functional readouts (replication stress, transformation, in vivo tumorigenesis); single lab","pmids":["23583447"],"is_preprint":false},{"year":2015,"finding":"Cyclin-A-CDK2 negatively regulates CIZ1 by phosphorylating it at threonines 144, 192, and 293. Phosphomimetic CIZ1 mutants fail to promote DNA replication in cell-free and cell-based assays and exert a dominant-negative effect on PCNA recruitment to replisomes. Phosphorylation blocks CIZ1 interaction with cyclin-A-CDK2 and prevents recruitment of endogenous cyclin A to the nuclear matrix; however, phosphomimetic CIZ1 retains nuclear matrix binding and interaction with CDC6. Phospho-T192-specific antibodies confirm that phosphorylation occurs during S phase and G2 at post-initiation cyclin-A-CDK2 concentrations.","method":"Site-directed mutagenesis (phosphomimetic), cell-free DNA replication assay, cell-based replication assay, co-immunoprecipitation, phospho-specific antibody, immunofluorescence","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution assay, mutagenesis of specific phosphosites, phospho-specific antibody validation, and multiple functional readouts in a single rigorous study","pmids":["25736292"],"is_preprint":false},{"year":2014,"finding":"CIZ1 interacts with TCF4 and activates β-catenin/TCF signaling in gallbladder cancer cells; CIZ1 overexpression promotes growth and migration while knockdown inhibits growth, migration, and tumorigenesis in vitro and in vivo.","method":"Co-immunoprecipitation (CIZ1–TCF4), luciferase reporter assay for β-catenin/TCF, siRNA knockdown, xenograft","journal":"Tumour biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP identifies binding partner, reporter assay shows signaling consequence; single lab, two orthogonal methods","pmids":["25427641"],"is_preprint":false},{"year":2016,"finding":"CIZ1 activates YAP transcriptional activity in hepatocellular carcinoma cells by physically interacting with YAP; the nuclear matrix anchor domain of CIZ1 mediates this interaction. CIZ1 also enhances the YAP–TEAD interaction. Knockdown of CIZ1 impairs YAP transcriptional activity and YAP-dependent cell growth and migration.","method":"Co-immunoprecipitation (CIZ1–YAP), domain deletion mapping, luciferase reporter assay (TEAD-dependent), siRNA knockdown","journal":"Tumour biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mapping and reporter assay; single lab, two orthogonal methods","pmids":["26906552"],"is_preprint":false},{"year":2017,"finding":"CIZ1 is recruited to the inactive X chromosome (Xi) in response to Xist RNA expression during the earliest stages of X inactivation in embryonic stem cells. Recruitment requires the C-terminal nuclear matrix anchor domain of CIZ1 and the E repeats of Xist RNA. In CIZ1-null mouse embryonic fibroblasts, Xist RNA localizes diffusely throughout the nucleoplasm rather than focally; re-expression of CIZ1 restores focal Xist localization. CIZ1-null mice display fully penetrant female-specific lymphoproliferative disorder.","method":"Immunofluorescence, RNA FISH, CIZ1-null mouse model, re-expression rescue experiment, domain deletion analysis (C-terminal anchor and Xist repeat E)","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — null mouse model, domain-mapped interaction, rescue experiment, and RNA FISH; multiple orthogonal methods, independently replicated with paper 28923964","pmids":["28546514"],"is_preprint":false},{"year":2017,"finding":"CIZ1 interacts directly with Xist RNA specifically through the highly repetitive Repeat E motif within Xist exon 7, shown at single-molecule level by STORM microscopy. Genetic loss of CIZ1 or deletion of Repeat E phenocopy each other, causing Xist RNA to delocalize from Xi into the nucleoplasm. Overexpression of CIZ1 similarly delocalizes Xist. CIZ1 delocalization is accompanied by decreased H3K27me3 at Xi.","method":"STORM super-resolution microscopy, genetic deletion (CIZ1 KO and Repeat E deletion), RNA FISH, ChIP (H3K27me3)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — STORM single-molecule imaging, reciprocal genetic epistasis with two independent deletions, and chromatin modification readout; multiple orthogonal methods","pmids":["28923964"],"is_preprint":false},{"year":2019,"finding":"CIZ1 is required for transient relocation of Xi from the nuclear periphery toward the nuclear interior during its replication in S phase. In CIZ1-null primary MEFs, this relocation is compromised and is accompanied by loss of PRC-mediated H2AK119Ub1 and H3K27me3, increased solubility of PRC2 catalytic subunit EZH2, and genome-wide deregulation of polycomb-regulated genes.","method":"Live-cell imaging and immunofluorescence (Xi position in S phase), CIZ1-null MEFs, ChIP (H2AK119Ub1, H3K27me3), nuclear fractionation (EZH2 solubility), transcriptomics","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — null cells with direct imaging of Xi positioning, histone mark ChIP, and fractionation; multiple orthogonal methods in one rigorous study","pmids":["30692537"],"is_preprint":false},{"year":2020,"finding":"CIZ1 interacts with DHX9 in vitro, and the two proteins dynamically co-localize within the nucleolus from early to mid S phase in an RNA polymerase I activity-dependent manner. Depletion of DHX9 abolishes CIZ1–DHX9 nucleolar co-localization and reduces G1-to-S-phase cell cycle progression in mouse fibroblasts.","method":"Molecular panning, mass spectrometry, in vitro binding, immunofluorescence co-localization, RNA Pol I inhibition, siRNA knockdown with cell cycle analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro interaction confirmed plus dynamic co-localization with functional perturbation; single lab, multiple methods","pmids":["33093612"],"is_preprint":false},{"year":2022,"finding":"CIZ1 undergoes two direct and independent interactions with Xist RNA, mediated by separate N-terminal and C-terminal domains. Two alternatively spliced glutamine-rich prion-like domains (PLD1 and PLD2) modulate CIZ1 assembly at Xi: PLD1 is required for both de novo assembly and accumulation at preexisting CIZ1-Xi assemblies and drives formation of a stable fibrillar network in vitro; PLD2 is required only for de novo assembly in CIZ1-null cells. CIZ1 self-assemblies formed in vitro are modulated by these PLDs.","method":"RNA immunoprecipitation (N- and C-terminal domain mapping), immunofluorescence in wild-type and CIZ1-null cells, in vitro self-assembly assay, domain deletion/mutation analysis","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of self-assemblies, domain-mapped RNA interactions, and functional rescue experiments in null cells; multiple orthogonal methods in one study","pmids":["35289833"],"is_preprint":false},{"year":2022,"finding":"The crystal structure of ERH bound to CIZ1 reveals that the ERH dimer binds two CIZ1 fragments (upstream of CIZ1's first zinc finger) to form a 2:2 heterotetramer. CIZ1 forms intermolecular antiparallel β-strands with ERH, and the ERH–CIZ1 binding surface is distinct from known ERH-binding ligands. Interface mutagenesis validated the interaction.","method":"Crystal structure determination, GST pull-down assay, site-directed mutagenesis of binding interface","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution crystal structure supplemented with mutagenesis and biochemical binding validation; multiple orthogonal methods","pmids":["36047590"],"is_preprint":false},{"year":2023,"finding":"CIZ1-null primary murine fibroblasts have reduced H4K20me1 (a mark placed by SET8), which compromises nuclear condensation on entry to quiescence. Re-expression of CIZ1 in null cells partially reverts the condensation defect. Repeated quiescence entry/exit cycles in CIZ1-null cells generate expanded, mechanically stressed nuclei, DNA damage checkpoint activation, and emergence of transformed colonies.","method":"CIZ1-null mouse fibroblasts, ChIP/immunofluorescence (H4K20me1), nuclear morphology imaging, SET8 manipulation, CIZ1 re-expression rescue, quiescence cycling assay, transformation assay","journal":"BMC biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — null cells with chromatin mark analysis, rescue experiment, and functional transformation readout; single lab, multiple methods","pmids":["37580709"],"is_preprint":false},{"year":2025,"finding":"CIZ1 is released from Xi during prometaphase under regulation of Aurora Kinase B (AURKB). The C-terminal 179/181 amino acids of human/mouse CIZ1 encode a matrin-3 domain that mediates CIZ1 dimerization forming a compact folded core with disordered C-terminal extensions. AURKB phosphorylates three conserved sites in these C-terminal extensions; phosphomimetic mutation at these sites releases CIZ1 from nuclear anchor points and abolishes CIZ1 interaction with RNA (including Xist) without affecting interaction with chromatin or nuclear matrix proteins.","method":"Mass spectrometry (56 interacting partners of C-terminal fragment), phosphomimetic and deletion mutagenesis, immunofluorescence (prometaphase CIZ1 release), RNA immunoprecipitation, AURKB inhibitor treatment","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — structure-informed mutagenesis of specific AURKB sites, MS-defined interactome, RNA-IP validation, and cell biological demonstration; multiple orthogonal methods in one study","pmids":["41626693"],"is_preprint":false},{"year":2025,"finding":"CIZ1 C-terminal anchor domain (AD) exerts a dominant-negative effect on CIZ1-Xi assembly reformation after mitosis, leading to abnormal assemblies depleted of H2AK119ub1 and H3K27me3 and loss of Xist focal localization, with consequent genome-wide deregulation of gene expression in a pattern consistent with unscheduled chromatin exposure to modifying enzymes.","method":"Ectopic AD expression (dominant-negative model), immunofluorescence (H2AK119ub1, H3K27me3, Xist RNA FISH), transcriptomics, human tumor transcriptome analysis","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — dominant-negative cellular model with histone mark and Xist localization readouts plus transcriptomic validation; single lab","pmids":["40067149"],"is_preprint":false},{"year":2025,"finding":"Med12 (a component of the Mediator kinase module with CDK8) is required for CIZ1 recruitment by Xist and H3K27me3 accumulation during initiation of X chromosome inactivation in mouse embryonic stem cells; CDK8 similarly modulates CIZ1 recruitment, placing the Mediator kinase module upstream of CIZ1 in the Xist silencing pathway.","method":"Med12 mutation in ESC model of X inactivation, immunofluorescence/RNA FISH for CIZ1 recruitment, CDK8 perturbation, H3K27me3 ChIP","journal":"Epigenetics reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in defined ESC model with direct localization and histone mark readouts; single lab","pmids":["41200585"],"is_preprint":false},{"year":2024,"finding":"CIZ1 ablation in fibroblasts causes a post-quiescent reduction in G1 length associated with elevated cyclin E1/E2 and A2 expression and enhanced Rb phosphorylation leading to early restriction-point bypass. CIZ1-null cells show deficient cyclin A chromatin binding and require a 2-fold higher CDK activity threshold for initiation of DNA replication, resulting in DNA replication stress in vitro and in vivo. Addition of recombinant CIZ1 reinstates cyclin A chromatin recruitment and restores the normal CDK threshold for initiation of DNA replication, reversing replication stress and increasing replication fork rates.","method":"Fucci(CA) live-cell imaging, cell-free DNA replication assay, DNA fiber combing, cyclin E1/E2/A2 expression analysis, Rb phosphorylation assay, recombinant CIZ1 add-back, CIZ1-KO fibroblasts","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — cell-free reconstitution with recombinant protein add-back, live imaging, and DNA fiber combing; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2024.09.02.610838"],"is_preprint":true}],"current_model":"CIZ1 is a nuclear matrix-associated protein with two functionally distinct modules: an N-terminal replication domain that cooperates with cyclin E and then cyclin A–CDK2 (sequentially via distinct cyclin-binding motifs) to promote initiation of mammalian DNA replication at licensed origins, and a C-terminal matrin-3/nuclear matrix anchor domain that immobilizes CIZ1 at replication factories and, in female cells, tethers it to large Xist RNA–dependent supramolecular assemblies at the inactive X chromosome; cyclin-A–CDK2 negatively feeds back by phosphorylating CIZ1 at T144/T192/T293 to block further initiation, while AURKB phosphorylates C-terminal extensions in mitosis to dissolve CIZ1–RNA assemblies; CIZ1 also binds p21(Cip1/Waf1), ERH, CDC6, TCF4, YAP, and DHX9 to coordinate cell-cycle progression, epigenetic maintenance (H2AK119ub1, H3K27me3, H4K20me1), and Xist-mediated gene silencing."},"narrative":{"mechanistic_narrative":"CIZ1 is a nuclear matrix-associated protein that couples cell-cycle-regulated DNA replication initiation to the spatial organization and epigenetic maintenance of chromatin [PMID:15585571, PMID:17182902]. Through an N-terminal replication domain it cooperates with cyclin E and then cyclin A–CDK2 — which it engages sequentially via distinct cyclin-binding motifs, cyclin A displacing cyclin E — to promote initiation of mammalian DNA replication at licensed origins, immobilizing cyclin-A kinase at subnuclear sites; depletion blocks S-phase entry despite chromatin loading of MCM and PCNA [PMID:15585571, PMID:20215406]. Cyclin-A–CDK2 then provides negative feedback by phosphorylating CIZ1 at threonines 144/192/293, which disrupts the CIZ1–cyclin-A–CDK2 interaction and blocks further initiation while preserving nuclear-matrix and CDC6 binding [PMID:25736292]. A C-terminal matrin-3 anchor domain mediates CIZ1 dimerization and immobilizes the protein at replication factories, and the same anchor tethers CIZ1 to the inactive X chromosome through direct, Repeat-E–dependent binding to Xist RNA, where it is required for focal Xist localization, transient S-phase repositioning of Xi, and Polycomb-mediated deposition of H2AK119ub1 and H3K27me3 [PMID:17182902, PMID:28546514, PMID:28923964, PMID:30692537, PMID:41626693]. Glutamine-rich prion-like domains drive CIZ1 self-assembly into fibrillar networks that build these supramolecular Xi assemblies, and Aurora kinase B phosphorylates the disordered C-terminal extensions in mitosis to release CIZ1 from RNA and dissolve the assemblies [PMID:35289833, PMID:41626693]. CIZ1 additionally controls the H4K20me1-dependent nuclear condensation that accompanies quiescence entry, and loss of CIZ1 causes replication stress, restriction-point bypass, and tumor-suppressor failure: CIZ1-null mice develop leukemias and a female-specific lymphoproliferative disorder [PMID:23583447, PMID:28546514, PMID:37580709]. A CIZ1 missense mutation that alters its splicing and nuclear localization is causal for adult-onset primary cervical dystonia [PMID:22447717]. Beyond its replication and chromatin roles, CIZ1 binds p21(Cip1/Waf1) and regulates its localization, and engages ERH, DHX9, TCF4, and YAP to modulate cell-cycle progression and transcriptional signaling [PMID:10529385, PMID:18081865, PMID:33093612, PMID:36047590].","teleology":[{"year":1999,"claim":"Established the first molecular handle on CIZ1 by showing it binds the CDK2-interacting region of the CDK inhibitor p21 and controls p21 subcellular localization, placing CIZ1 at the cell-cycle machinery.","evidence":"Yeast two-hybrid, co-IP and immunofluorescence in U2-OS cells","pmids":["10529385"],"confidence":"Medium","gaps":["Functional consequence for cell-cycle progression not tested","Did not address whether p21 binding competes with other CIZ1 partners"]},{"year":2003,"claim":"Asked whether CIZ1 contacts DNA directly and defined a consensus binding sequence, indicating a chromatin-associated rather than purely protein-scaffolding role.","evidence":"SAAB sequence selection and EMSA, with nuclear immunofluorescence across tissues","pmids":["12824700"],"confidence":"Medium","gaps":["Genomic targets of the consensus in vivo not identified","Link between DNA binding and replication function not established"]},{"year":2004,"claim":"Defined CIZ1's core function as a positive regulator of mammalian DNA replication initiation acting downstream of origin licensing, the keystone mechanistic finding.","evidence":"Cell-free replication reconstitution with recombinant protein, GFP overexpression, CDK-site mutagenesis, RNAi with BrdU and chromatin-bound MCM3/PCNA analysis","pmids":["15585571"],"confidence":"High","gaps":["Identity of the cyclin/CDK partner driving initiation not yet defined","Did not resolve how CIZ1 is positioned at origins"]},{"year":2007,"claim":"Resolved how CIZ1 is spatially organized, mapping a C-terminal nuclear-matrix anchor (aa 708–830) that immobilizes CIZ1 at replication factories in a cell-cycle-dependent manner, while N-terminal domains specify focal patterning.","evidence":"GFP-fragment domain mapping, nuclear matrix fractionation, co-localization with BrdU replication sites","pmids":["17182902"],"confidence":"High","gaps":["Molecular nature of the matrix attachment partner not defined","How anchoring is timed to late G1/early S not resolved"]},{"year":2007,"claim":"Showed that splice variants and partner recruitment shape CIZ1 function: a cancer-associated ΔE4 isoform separates replication activity from foci formation and acts dominant-negatively, and CIZ1 recruits ERH to replication foci through a region overlapping the p21 site.","evidence":"Exon-trap splicing assay and dominant-negative coexpression (ΔE4); yeast two-hybrid, GST pull-down and MS (ERH)","pmids":["17508423","18081865"],"confidence":"Medium","gaps":["Functional role of ERH recruitment at replication foci untested","Whether p21 and ERH binding are mutually exclusive in vivo not shown"]},{"year":2008,"claim":"Refined the matrix-association determinant to a 28-residue glutamine-rich element encoded by exon 8, linking alternative splicing of this region to CIZ1 foci formation.","evidence":"Immunofluorescence, nuclear matrix fractionation and deletion analysis in transfected cells","pmids":["18583151"],"confidence":"Medium","gaps":["Did not connect the Q-rich element to later-defined prion-like self-assembly","Physiological regulation of exon 8 splicing not addressed"]},{"year":2010,"claim":"Identified the cyclin partners and the mechanism of initiation, showing CIZ1 binds cyclin E then cyclin A through distinct motifs and immobilizes cyclin-A–CDK2 at subnuclear sites to drive replication.","evidence":"Cell-free reconstitution with recombinant cyclin-A–CDK2 and CIZ1, co-IP cyclin displacement, RNAi with cyclin A localization imaging","pmids":["20215406"],"confidence":"High","gaps":["How the sequential cyclin switch is temporally controlled not resolved","Origin specificity of CIZ1-targeted cyclin A not mapped"]},{"year":2012,"claim":"Extended CIZ1 function beyond somatic replication, linking it to germ-cell cyclin A1 and DSB repair, and identifying a causal dystonia mutation that alters CIZ1 splicing and localization.","evidence":"Co-IP and in vitro plasmid repair assay in testis extract; exome sequencing and minigene splicing assay (S264G)","pmids":["22366453","22447717"],"confidence":"Medium","gaps":["Direct repair substrate and mechanism for CIZ1 in germ cells not defined","How the dystonia mutation produces neuronal pathology not established"]},{"year":2013,"claim":"Established CIZ1 as a bona fide tumor suppressor in vivo, with null cells sensitive to replication stress and prone to transformation and null mice developing leukemias.","evidence":"CIZ1-knockout mice, hydroxyurea sensitivity, oncogene transformation in MEFs, retroviral insertional mutagenesis","pmids":["23583447"],"confidence":"Medium","gaps":["Mechanistic link between replication-stress sensitivity and tumorigenesis not fully resolved","Tissue specificity of tumor spectrum unexplained"]},{"year":2015,"claim":"Defined a negative feedback loop in which cyclin-A–CDK2 phosphorylates CIZ1 at T144/T192/T293 to terminate further initiation while sparing matrix and CDC6 binding.","evidence":"Phosphomimetic mutagenesis, cell-free and cell-based replication assays, co-IP, phospho-T192 antibody, immunofluorescence","pmids":["25736292"],"confidence":"High","gaps":["Phosphatase that resets CIZ1 not identified","How feedback restricts initiation to once-per-cycle not fully mechanistic"]},{"year":2017,"claim":"Revealed a distinct CIZ1 role at the inactive X chromosome, showing its C-terminal anchor binds Repeat E of Xist RNA to retain Xist focally and maintain H3K27me3, establishing CIZ1 as an Xist-tethering factor.","evidence":"CIZ1-null mice with rescue, RNA FISH, STORM single-molecule imaging, reciprocal CIZ1/Repeat-E deletions, H3K27me3 ChIP","pmids":["28546514","28923964"],"confidence":"High","gaps":["How RNA binding and matrix anchoring are coordinated not resolved","Whether the same anchor mediates both replication and Xi roles unresolved at this stage"]},{"year":2019,"claim":"Connected CIZ1's replication and Xi functions by showing CIZ1 is required for S-phase repositioning of Xi and for stable PRC1/PRC2 deposition (H2AK119ub1, H3K27me3) and EZH2 retention.","evidence":"Live imaging and immunofluorescence of Xi position, CIZ1-null MEFs, histone-mark ChIP, EZH2 fractionation, transcriptomics","pmids":["30692537"],"confidence":"High","gaps":["Direct link between Xi repositioning and PRC retention mechanistically unproven","How replication timing intersects with CIZ1-Xi assembly unresolved"]},{"year":2020,"claim":"Added a nucleolar dimension, identifying DHX9 as a CIZ1 partner whose RNA Pol I–dependent co-localization supports G1-to-S progression.","evidence":"Molecular panning/MS, in vitro binding, co-localization with Pol I inhibition, siRNA with cell-cycle analysis","pmids":["33093612"],"confidence":"Medium","gaps":["Mechanism by which CIZ1–DHX9 promotes S-phase entry not defined","Single-lab in vitro interaction without reciprocal in vivo validation"]},{"year":2022,"claim":"Provided the structural and biophysical basis for CIZ1 assembly, defining two independent Xist-binding domains, two glutamine-rich prion-like domains driving fibrillar self-assembly, and the atomic ERH–CIZ1 heterotetramer interface.","evidence":"RNA-IP domain mapping, in vitro self-assembly assays and rescue in null cells (PLDs); crystal structure with interface mutagenesis (ERH)","pmids":["35289833","36047590"],"confidence":"High","gaps":["Functional role of ERH binding in replication or Xi assembly not established","How PLD-driven self-assembly is regulated in cells not resolved"]},{"year":2023,"claim":"Linked CIZ1 to quiescence by showing it sustains H4K20me1 needed for nuclear condensation, and that repeated quiescence cycling without CIZ1 drives genome instability and transformation.","evidence":"CIZ1-null fibroblasts, H4K20me1 ChIP/IF, nuclear morphology imaging, SET8 manipulation, rescue and quiescence cycling/transformation assays","pmids":["37580709"],"confidence":"Medium","gaps":["How CIZ1 supports SET8-dependent H4K20me1 mechanistically unknown","Causal chain from condensation defect to transformation not fully established"]},{"year":2025,"claim":"Defined the mitotic regulation and structural architecture of the CIZ1 anchor, showing the matrin-3 domain dimerizes into a folded core with disordered extensions that AURKB phosphorylates to release CIZ1 from RNA and Xi during prometaphase, and that the anchor domain acts dominant-negatively to disrupt post-mitotic Xi reassembly and Polycomb marks.","evidence":"MS interactome, structure-informed phosphomimetic/deletion mutagenesis, RNA-IP, AURKB inhibition, prometaphase imaging; ectopic anchor-domain dominant-negative model with histone-mark/Xist FISH and tumor transcriptomics","pmids":["41626693","40067149"],"confidence":"High","gaps":["How AURKB phosphorylation is reversed to permit reassembly not resolved","Whether mitotic release is selectively used at Xi versus replication factories unclear"]},{"year":2025,"claim":"Placed CIZ1 within an upstream regulatory pathway by showing the Mediator kinase module (Med12/CDK8) is required for Xist-directed CIZ1 recruitment and H3K27me3 accumulation at the onset of X inactivation.","evidence":"Med12 mutation and CDK8 perturbation in an ESC X-inactivation model with CIZ1 recruitment imaging and H3K27me3 ChIP","pmids":["41200585"],"confidence":"Medium","gaps":["Whether Mediator kinase acts directly on CIZ1 or via intermediates unknown","Single-lab genetic epistasis without biochemical mechanism"]},{"year":null,"claim":"How CIZ1's replication-initiation activity and Xist-tethering activity are mechanistically integrated through a shared anchor and self-assembly machinery, and what resets the system between cell cycles, remains open.","evidence":"","pmids":[],"confidence":"High","gaps":["No phosphatase or reset mechanism for cyclin-A or AURKB phosphorylation identified","Direct structural model of CIZ1 at an origin versus at Xi not resolved","Mechanism linking transcriptional coactivator roles (YAP/TCF4/ERα) to the matrix/replication functions undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[16,19,22]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[4,22]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[8,12]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,8]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,13,14]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[15,16,17]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[4,15]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[18]}],"pathway":[{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[2,8,12]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[8,12,25]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[16,17,21,23]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[16,17,23]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,9]}],"complexes":["CIZ1–Xist RNA assembly at inactive X chromosome","ERH–CIZ1 2:2 heterotetramer"],"partners":["CCNA2","CCNE1","CDK2","CDKN1A","ERH","DHX9","CDC6","YAP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9ULV3","full_name":"Cip1-interacting zinc finger protein","aliases":["CDKN1A-interacting zinc finger protein 1","Nuclear protein NP94","Zinc finger protein 356"],"length_aa":898,"mass_kda":100.0,"function":"May regulate the subcellular localization of CIP/WAF1","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9ULV3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CIZ1","classification":"Not Classified","n_dependent_lines":84,"n_total_lines":1208,"dependency_fraction":0.0695364238410596},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DYNLL1","stoichiometry":0.2},{"gene":"DYNLL2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/CIZ1","total_profiled":1310},"omim":[{"mim_id":"614860","title":"DYSTONIA 23; DYT23","url":"https://www.omim.org/entry/614860"},{"mim_id":"611420","title":"CDKN1A-INTERACTING ZINC FINGER PROTEIN 1; CIZ1","url":"https://www.omim.org/entry/611420"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CIZ1"},"hgnc":{"alias_symbol":["LSFR1","ZNF356"],"prev_symbol":[]},"alphafold":{"accession":"Q9ULV3","domains":[{"cath_id":"-","chopping":"799-831","consensus_level":"medium","plddt":85.1924,"start":799,"end":831}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9ULV3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9ULV3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9ULV3-F1-predicted_aligned_error_v6.png","plddt_mean":52.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CIZ1","jax_strain_url":"https://www.jax.org/strain/search?query=CIZ1"},"sequence":{"accession":"Q9ULV3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9ULV3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9ULV3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9ULV3"}},"corpus_meta":[{"pmid":"22447717","id":"PMC_22447717","title":"Mutations in CIZ1 cause adult onset primary cervical dystonia.","date":"2012","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22447717","citation_count":110,"is_preprint":false},{"pmid":"28546514","id":"PMC_28546514","title":"The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory.","date":"2017","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/28546514","citation_count":102,"is_preprint":false},{"pmid":"28923964","id":"PMC_28923964","title":"Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1).","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28923964","citation_count":98,"is_preprint":false},{"pmid":"15585571","id":"PMC_15585571","title":"Ciz1 promotes mammalian DNA replication.","date":"2004","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15585571","citation_count":61,"is_preprint":false},{"pmid":"19124469","id":"PMC_19124469","title":"Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19124469","citation_count":59,"is_preprint":false},{"pmid":"10529385","id":"PMC_10529385","title":"Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10529385","citation_count":57,"is_preprint":false},{"pmid":"17108141","id":"PMC_17108141","title":"Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17108141","citation_count":48,"is_preprint":false},{"pmid":"23074256","id":"PMC_23074256","title":"Variant Ciz1 is a circulating biomarker for early-stage lung cancer.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23074256","citation_count":47,"is_preprint":false},{"pmid":"17182902","id":"PMC_17182902","title":"C-terminal domains deliver the DNA replication factor Ciz1 to the nuclear matrix.","date":"2007","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17182902","citation_count":42,"is_preprint":false},{"pmid":"20215406","id":"PMC_20215406","title":"Ciz1 cooperates with cyclin-A-CDK2 to activate mammalian DNA replication in vitro.","date":"2010","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/20215406","citation_count":37,"is_preprint":false},{"pmid":"32088211","id":"PMC_32088211","title":"Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32088211","citation_count":37,"is_preprint":false},{"pmid":"12824700","id":"PMC_12824700","title":"Ciz1, Cip1 interacting zinc finger protein 1 binds the consensus DNA sequence ARYSR(0-2)YYAC.","date":"2003","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/12824700","citation_count":36,"is_preprint":false},{"pmid":"18583151","id":"PMC_18583151","title":"Altered splicing in exon 8 of the DNA replication factor CIZ1 affects subnuclear distribution and is associated with Alzheimer's disease.","date":"2008","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/18583151","citation_count":30,"is_preprint":false},{"pmid":"18081865","id":"PMC_18081865","title":"Ciz1, a p21 cip1/Waf1-interacting zinc finger protein and DNA replication factor, is a novel molecular partner for human enhancer of rudimentary homolog.","date":"2007","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/18081865","citation_count":28,"is_preprint":false},{"pmid":"29154038","id":"PMC_29154038","title":"DNA damage and neurodegenerative phenotypes in aged Ciz1 null mice.","date":"2018","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/29154038","citation_count":27,"is_preprint":false},{"pmid":"17508423","id":"PMC_17508423","title":"Cancer-associated missplicing of exon 4 influences the subnuclear distribution of the DNA replication factor CIZ1.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17508423","citation_count":27,"is_preprint":false},{"pmid":"25736292","id":"PMC_25736292","title":"Cyclin-A-CDK2-mediated phosphorylation of CIZ1 blocks replisome formation and initiation of mammalian DNA replication.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25736292","citation_count":26,"is_preprint":false},{"pmid":"32196604","id":"PMC_32196604","title":"Upregulation of lncRNA DANCR functions as an oncogenic role in non-small lung cancer by regulating miR-214-5p/CIZ1 axis.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32196604","citation_count":23,"is_preprint":false},{"pmid":"22366453","id":"PMC_22366453","title":"Cancer-associated variant expression and interaction of CIZ1 with cyclin A1 in differentiating male germ cells.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22366453","citation_count":21,"is_preprint":false},{"pmid":"20831784","id":"PMC_20831784","title":"Differential detection of alternatively spliced variants of Ciz1 in normal and cancer cells using a custom exon-junction microarray.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20831784","citation_count":20,"is_preprint":false},{"pmid":"25427641","id":"PMC_25427641","title":"CIZ1 promoted the growth and migration of gallbladder cancer cells.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25427641","citation_count":19,"is_preprint":false},{"pmid":"24928862","id":"PMC_24928862","title":"Ciz1 is a novel predictor of survival in human colon cancer.","date":"2014","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/24928862","citation_count":19,"is_preprint":false},{"pmid":"24126760","id":"PMC_24126760","title":"CIZ1 regulates the proliferation, cycle distribution and colony formation of RKO human colorectal cancer cells.","date":"2013","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/24126760","citation_count":17,"is_preprint":false},{"pmid":"23583447","id":"PMC_23583447","title":"CIZ1, a p21Cip1/Waf1-interacting protein, functions as a tumor suppressor in vivo.","date":"2013","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/23583447","citation_count":17,"is_preprint":false},{"pmid":"25553473","id":"PMC_25553473","title":"Ciz1 promotes tumorigenicity of prostate carcinoma cells.","date":"2015","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/25553473","citation_count":17,"is_preprint":false},{"pmid":"26861296","id":"PMC_26861296","title":"The Role of Cdkn1A-Interacting Zinc Finger Protein 1 (CIZ1) in DNA Replication and Pathophysiology.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26861296","citation_count":14,"is_preprint":false},{"pmid":"28036012","id":"PMC_28036012","title":"Emerging Roles for Ciz1 in Cell Cycle Regulation and as a Driver of Tumorigenesis.","date":"2016","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/28036012","citation_count":13,"is_preprint":false},{"pmid":"35289833","id":"PMC_35289833","title":"Prion-like domains drive CIZ1 assembly formation at the inactive X chromosome.","date":"2022","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35289833","citation_count":13,"is_preprint":false},{"pmid":"26515335","id":"PMC_26515335","title":"CIZ1 is upregulated in hepatocellular carcinoma and promotes the growth and migration of the cancer cells.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26515335","citation_count":13,"is_preprint":false},{"pmid":"27163549","id":"PMC_27163549","title":"Motor phenotypes and molecular networks associated with germline deficiency of Ciz1.","date":"2016","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27163549","citation_count":12,"is_preprint":false},{"pmid":"30692537","id":"PMC_30692537","title":"Maintenance of epigenetic landscape requires CIZ1 and is corrupted in differentiated fibroblasts in long-term culture.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30692537","citation_count":10,"is_preprint":false},{"pmid":"26906552","id":"PMC_26906552","title":"CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26906552","citation_count":9,"is_preprint":false},{"pmid":"31252164","id":"PMC_31252164","title":"CIZ1 knockdown suppresses the proliferation of bladder cancer cells by inducing apoptosis.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31252164","citation_count":9,"is_preprint":false},{"pmid":"33093612","id":"PMC_33093612","title":"Identification of DHX9 as a cell cycle regulated nucleolar recruitment factor for CIZ1.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33093612","citation_count":8,"is_preprint":false},{"pmid":"36047590","id":"PMC_36047590","title":"Molecular basis for the recognition of CIZ1 by ERH.","date":"2022","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/36047590","citation_count":5,"is_preprint":false},{"pmid":"30280956","id":"PMC_30280956","title":"CIZ1-F, an alternatively spliced variant of the DNA replication protein CIZ1 with distinct expression and localisation, is overrepresented in early stage common solid tumours.","date":"2018","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/30280956","citation_count":5,"is_preprint":false},{"pmid":"22075938","id":"PMC_22075938","title":"Clobetasol synergistically diminishes Ciz1 expression with genistein in U937 cells.","date":"2011","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/22075938","citation_count":3,"is_preprint":false},{"pmid":"27934662","id":"PMC_27934662","title":"Cardiomyocyte--specific expression of the nuclear matrix protein, CIZ1, stimulates production of mono-nucleated cells with an extended window of proliferation in the postnatal mouse heart.","date":"2017","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/27934662","citation_count":3,"is_preprint":false},{"pmid":"40067149","id":"PMC_40067149","title":"Epigenetic deprogramming by disruption of CIZ1-RNA nuclear assemblies in early-stage breast cancers.","date":"2025","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/40067149","citation_count":2,"is_preprint":false},{"pmid":"30456533","id":"PMC_30456533","title":"CIZ1 Expression Is Upregulated in Hemangioma of the Tongue.","date":"2018","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/30456533","citation_count":2,"is_preprint":false},{"pmid":"38155839","id":"PMC_38155839","title":"CIZ1 in Xist seeded assemblies at the inactive X chromosome.","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/38155839","citation_count":1,"is_preprint":false},{"pmid":"30098009","id":"PMC_30098009","title":"Consequences of Cre-mediated deletion of Ciz1 exon 5 in mice.","date":"2018","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/30098009","citation_count":1,"is_preprint":false},{"pmid":"37954363","id":"PMC_37954363","title":"CIZ1 aggravates gastric cancer progression via mediating FBXL19-AS1 and miR-339-3p.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/37954363","citation_count":0,"is_preprint":false},{"pmid":"37580709","id":"PMC_37580709","title":"Epigenetic instability caused by absence of CIZ1 drives transformation during quiescence cycles.","date":"2023","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/37580709","citation_count":0,"is_preprint":false},{"pmid":"41626693","id":"PMC_41626693","title":"AURKB-driven dissolution of CIZ1-RNA assemblies from the inactive X chromosome in mitosis.","date":"2026","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/41626693","citation_count":0,"is_preprint":false},{"pmid":"41200585","id":"PMC_41200585","title":"Implication of the Mediator kinase module in CIZ1 recruitment and gene silencing by Xist during the initiation of X inactivation.","date":"2025","source":"Epigenetics reports","url":"https://pubmed.ncbi.nlm.nih.gov/41200585","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.02.610838","title":"CIZ1 regulates G1 length and the CDK threshold for initiation of DNA replication to prevent DNA replication stress","date":"2024-09-03","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.02.610838","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.22.609161","title":"Epigenetic deprogramming driven by disruption of CIZ1-RNA nuclear assemblies in early-stage breast cancers","date":"2024-08-22","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.22.609161","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":22709,"output_tokens":7211,"usd":0.088146,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16569,"output_tokens":6445,"usd":0.121985,"stage2_stop_reason":"end_turn"},"total_usd":0.210131,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"CIZ1 (Ciz1) binds directly to the N-terminal, CDK2-interacting part of p21(Cip1/Waf1) through a region of ~150 amino acids containing its first zinc-finger motif; this interaction is disrupted by overexpression of CDK2. Coexpression of Ciz1 with p21 induces cytoplasmic redistribution of p21, showing Ciz1 regulates p21 subcellular localization.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, immunofluorescence, overexpression in U2-OS cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal binding mapped to specific domain, functional localization consequence shown, single lab with two orthogonal methods\",\n      \"pmids\": [\"10529385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CIZ1 binds DNA directly and recognizes the consensus sequence ARYSR(0-2)YYAC, as determined by a modified SAAB (selected and amplified binding) method and confirmed by electrophoretic mobility shift assays. CIZ1 localizes to the nucleus in a broad range of tissues.\",\n      \"method\": \"SAAB sequence selection, EMSA, immunofluorescence, Northern blot\",\n      \"journal\": \"Journal of biomedical science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — DNA-binding consensus established by SAAB and validated by EMSA, single lab, two orthogonal methods\",\n      \"pmids\": [\"12824700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Ciz1 promotes initiation of mammalian DNA replication: recombinant Ciz1 increases the number of nuclei initiating DNA replication in a cell-free reconstitution system; GFP-Ciz1 stimulates DNA synthesis in intact cells; mutation of putative CDK phosphorylation sites at threonines 191/192 alters Ciz1 activity in vitro. Endogenous Ciz1 localizes to nuclear foci co-localizing with PCNA during S phase, and RNAi depletion of Ciz1 inhibits S-phase entry with accumulation of chromatin-bound Mcm3 and PCNA but failure to synthesize DNA.\",\n      \"method\": \"Cell-free DNA replication reconstitution assay, GFP overexpression in intact cells, site-directed mutagenesis, immunofluorescence co-localization with PCNA, RNAi knockdown with flow cytometry and BrdU incorporation\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cell-free reconstitution with recombinant protein, mutagenesis of functional sites, and multiple cellular assays in a single study\",\n      \"pmids\": [\"15585571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Ciz1 functions as a coactivator of estrogen receptor alpha (ERα): Ciz1 protein binds directly to ERα-associated chromatin, enhances ER transactivation activity, and promotes recruitment of the ER complex to target gene chromatin. Ciz1 overexpression confers estrogen hypersensitivity and promotes anchorage-independent growth and tumorigenicity in breast cancer cells.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), reporter transactivation assay, proliferation and colony formation assays, xenograft\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrates chromatin recruitment and transactivation assay shows functional consequence; single lab, two orthogonal methods\",\n      \"pmids\": [\"17108141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CIZ1 is immobilized at the nuclear matrix through sequences in its C-terminal third (amino acids 708–830), in a cell-cycle-dependent manner coinciding with late G1/early S phase. Matrix-associated CIZ1 foci co-localize with sites of newly synthesized DNA (replication factories). N-terminal domains are additionally required to specify focal organization, while C-terminal domains alone are sufficient for nuclear matrix immobilization.\",\n      \"method\": \"GFP-tagged fragment analysis, nuclease and high-salt extraction (nuclear matrix fractionation), immunofluorescence co-localization with BrdU-labeled replication sites\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain mapping by deletion analysis combined with nuclear matrix fractionation and direct co-localization with replication sites; multiple orthogonal methods in one study\",\n      \"pmids\": [\"17182902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Ciz1 interacts with ERH (enhancer of rudimentary homolog) through residues 531–644 encompassing its first zinc finger motif; this region overlaps the p21(Cip1/Waf1)-binding site, suggesting competitive binding. When coexpressed, Ciz1 recruits ERH to DNA replication foci in HeLa cells.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down assay, tandem MS, immunofluorescence co-localization\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GST pull-down and yeast two-hybrid plus MS identification; functional recruitment shown by co-localization; single lab\",\n      \"pmids\": [\"18081865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A cancer-associated alternatively spliced CIZ1 variant lacking exon 4 (ΔE4) retains replication activity but fails to form subnuclear foci. Coexpression of mouse ΔE4 with wild-type Ciz1 prevents normal Ciz1 focal localization, exerting a dominant-negative effect on foci formation. Exon 4 skipping is caused by expansion of an intronic mononucleotide repeat in Ewing tumor cell lines.\",\n      \"method\": \"Exon-trap splicing assay, immunofluorescence, dominant-negative coexpression experiment, sequencing\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays (splicing and dominant-negative localization) combined with molecular characterization; single lab, two orthogonal methods\",\n      \"pmids\": [\"17508423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A CIZ1 isoform lacking the glutamine-rich region encoded by exon 8 (due to alternative splicing) loses the ability to associate with the nuclear matrix and form nuclear foci; a minimal 28 amino acid sequence within this glutamine-rich region is required for nuclear matrix association and foci formation.\",\n      \"method\": \"Immunofluorescence, nuclear matrix fractionation, domain deletion analysis in transfected cells\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain identified by deletion analysis with functional nuclear matrix fractionation readout; single lab\",\n      \"pmids\": [\"18583151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ciz1 interacts with cyclin E and cyclin A sequentially through distinct cyclin-binding motifs; cyclin A displaces cyclin E from Ciz1. In cell-free assays, recombinant cyclin-A-CDK2 and recombinant Ciz1 cooperate to promote initiation of DNA replication in late G1-phase nuclei. Ciz1 immobilizes cyclin A in isolated nuclei and RNAi depletion of Ciz1 impairs cyclin A nuclear immobilization, indicating Ciz1 targets cyclin-A kinase to specific subnuclear sites.\",\n      \"method\": \"Cell-free DNA replication reconstitution assay with recombinant proteins, co-immunoprecipitation (cyclin E/A displacement), RNAi knockdown with immunofluorescence for cyclin A localization\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cell-free reconstitution with recombinant proteins, domain-mapped sequential cyclin interactions, and RNAi functional validation; multiple orthogonal methods\",\n      \"pmids\": [\"20215406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A missense mutation in CIZ1 (c.790A>G, p.S264G), identified as causal for adult-onset primary cervical dystonia, alters CIZ1 splicing patterns (demonstrated by minigene assay) and alters the nuclear localization of CIZ1.\",\n      \"method\": \"Exome sequencing, minigene splicing assay, immunofluorescence for nuclear localization\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — minigene assay directly demonstrates splice alteration and localization change shown; single lab, two methods\",\n      \"pmids\": [\"22447717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In non-proliferating spermatocytes, CIZ1 interacts with germ-cell-specific cyclin A1 (distinct from somatic cyclin A2). Antibody depletion of CIZ1 from testis extract reduces the capacity to repair digested plasmid DNA in vitro, suggesting a post-replicative role for CIZ1 in DNA double-strand break repair in germ cells.\",\n      \"method\": \"Co-immunoprecipitation (CIZ1–cyclin A1), in vitro plasmid repair assay with antibody depletion\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP identifies binding partner and in vitro depletion assay demonstrates functional consequence; single lab, two methods\",\n      \"pmids\": [\"22366453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CIZ1-null MEFs are sensitive to hydroxyurea-induced replication stress and susceptible to oncogene-induced cellular transformation; Ciz1-null mice developed various leukemias in a retroviral insertional mutagenesis model, establishing CIZ1 as a tumor suppressor in vivo.\",\n      \"method\": \"Knockout mouse model, hydroxyurea sensitivity assay, oncogene transformation assay in MEFs, retroviral insertional mutagenesis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple orthogonal functional readouts (replication stress, transformation, in vivo tumorigenesis); single lab\",\n      \"pmids\": [\"23583447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cyclin-A-CDK2 negatively regulates CIZ1 by phosphorylating it at threonines 144, 192, and 293. Phosphomimetic CIZ1 mutants fail to promote DNA replication in cell-free and cell-based assays and exert a dominant-negative effect on PCNA recruitment to replisomes. Phosphorylation blocks CIZ1 interaction with cyclin-A-CDK2 and prevents recruitment of endogenous cyclin A to the nuclear matrix; however, phosphomimetic CIZ1 retains nuclear matrix binding and interaction with CDC6. Phospho-T192-specific antibodies confirm that phosphorylation occurs during S phase and G2 at post-initiation cyclin-A-CDK2 concentrations.\",\n      \"method\": \"Site-directed mutagenesis (phosphomimetic), cell-free DNA replication assay, cell-based replication assay, co-immunoprecipitation, phospho-specific antibody, immunofluorescence\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution assay, mutagenesis of specific phosphosites, phospho-specific antibody validation, and multiple functional readouts in a single rigorous study\",\n      \"pmids\": [\"25736292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CIZ1 interacts with TCF4 and activates β-catenin/TCF signaling in gallbladder cancer cells; CIZ1 overexpression promotes growth and migration while knockdown inhibits growth, migration, and tumorigenesis in vitro and in vivo.\",\n      \"method\": \"Co-immunoprecipitation (CIZ1–TCF4), luciferase reporter assay for β-catenin/TCF, siRNA knockdown, xenograft\",\n      \"journal\": \"Tumour biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP identifies binding partner, reporter assay shows signaling consequence; single lab, two orthogonal methods\",\n      \"pmids\": [\"25427641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CIZ1 activates YAP transcriptional activity in hepatocellular carcinoma cells by physically interacting with YAP; the nuclear matrix anchor domain of CIZ1 mediates this interaction. CIZ1 also enhances the YAP–TEAD interaction. Knockdown of CIZ1 impairs YAP transcriptional activity and YAP-dependent cell growth and migration.\",\n      \"method\": \"Co-immunoprecipitation (CIZ1–YAP), domain deletion mapping, luciferase reporter assay (TEAD-dependent), siRNA knockdown\",\n      \"journal\": \"Tumour biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mapping and reporter assay; single lab, two orthogonal methods\",\n      \"pmids\": [\"26906552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CIZ1 is recruited to the inactive X chromosome (Xi) in response to Xist RNA expression during the earliest stages of X inactivation in embryonic stem cells. Recruitment requires the C-terminal nuclear matrix anchor domain of CIZ1 and the E repeats of Xist RNA. In CIZ1-null mouse embryonic fibroblasts, Xist RNA localizes diffusely throughout the nucleoplasm rather than focally; re-expression of CIZ1 restores focal Xist localization. CIZ1-null mice display fully penetrant female-specific lymphoproliferative disorder.\",\n      \"method\": \"Immunofluorescence, RNA FISH, CIZ1-null mouse model, re-expression rescue experiment, domain deletion analysis (C-terminal anchor and Xist repeat E)\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — null mouse model, domain-mapped interaction, rescue experiment, and RNA FISH; multiple orthogonal methods, independently replicated with paper 28923964\",\n      \"pmids\": [\"28546514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CIZ1 interacts directly with Xist RNA specifically through the highly repetitive Repeat E motif within Xist exon 7, shown at single-molecule level by STORM microscopy. Genetic loss of CIZ1 or deletion of Repeat E phenocopy each other, causing Xist RNA to delocalize from Xi into the nucleoplasm. Overexpression of CIZ1 similarly delocalizes Xist. CIZ1 delocalization is accompanied by decreased H3K27me3 at Xi.\",\n      \"method\": \"STORM super-resolution microscopy, genetic deletion (CIZ1 KO and Repeat E deletion), RNA FISH, ChIP (H3K27me3)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — STORM single-molecule imaging, reciprocal genetic epistasis with two independent deletions, and chromatin modification readout; multiple orthogonal methods\",\n      \"pmids\": [\"28923964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CIZ1 is required for transient relocation of Xi from the nuclear periphery toward the nuclear interior during its replication in S phase. In CIZ1-null primary MEFs, this relocation is compromised and is accompanied by loss of PRC-mediated H2AK119Ub1 and H3K27me3, increased solubility of PRC2 catalytic subunit EZH2, and genome-wide deregulation of polycomb-regulated genes.\",\n      \"method\": \"Live-cell imaging and immunofluorescence (Xi position in S phase), CIZ1-null MEFs, ChIP (H2AK119Ub1, H3K27me3), nuclear fractionation (EZH2 solubility), transcriptomics\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — null cells with direct imaging of Xi positioning, histone mark ChIP, and fractionation; multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"30692537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CIZ1 interacts with DHX9 in vitro, and the two proteins dynamically co-localize within the nucleolus from early to mid S phase in an RNA polymerase I activity-dependent manner. Depletion of DHX9 abolishes CIZ1–DHX9 nucleolar co-localization and reduces G1-to-S-phase cell cycle progression in mouse fibroblasts.\",\n      \"method\": \"Molecular panning, mass spectrometry, in vitro binding, immunofluorescence co-localization, RNA Pol I inhibition, siRNA knockdown with cell cycle analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro interaction confirmed plus dynamic co-localization with functional perturbation; single lab, multiple methods\",\n      \"pmids\": [\"33093612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CIZ1 undergoes two direct and independent interactions with Xist RNA, mediated by separate N-terminal and C-terminal domains. Two alternatively spliced glutamine-rich prion-like domains (PLD1 and PLD2) modulate CIZ1 assembly at Xi: PLD1 is required for both de novo assembly and accumulation at preexisting CIZ1-Xi assemblies and drives formation of a stable fibrillar network in vitro; PLD2 is required only for de novo assembly in CIZ1-null cells. CIZ1 self-assemblies formed in vitro are modulated by these PLDs.\",\n      \"method\": \"RNA immunoprecipitation (N- and C-terminal domain mapping), immunofluorescence in wild-type and CIZ1-null cells, in vitro self-assembly assay, domain deletion/mutation analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of self-assemblies, domain-mapped RNA interactions, and functional rescue experiments in null cells; multiple orthogonal methods in one study\",\n      \"pmids\": [\"35289833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The crystal structure of ERH bound to CIZ1 reveals that the ERH dimer binds two CIZ1 fragments (upstream of CIZ1's first zinc finger) to form a 2:2 heterotetramer. CIZ1 forms intermolecular antiparallel β-strands with ERH, and the ERH–CIZ1 binding surface is distinct from known ERH-binding ligands. Interface mutagenesis validated the interaction.\",\n      \"method\": \"Crystal structure determination, GST pull-down assay, site-directed mutagenesis of binding interface\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution crystal structure supplemented with mutagenesis and biochemical binding validation; multiple orthogonal methods\",\n      \"pmids\": [\"36047590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CIZ1-null primary murine fibroblasts have reduced H4K20me1 (a mark placed by SET8), which compromises nuclear condensation on entry to quiescence. Re-expression of CIZ1 in null cells partially reverts the condensation defect. Repeated quiescence entry/exit cycles in CIZ1-null cells generate expanded, mechanically stressed nuclei, DNA damage checkpoint activation, and emergence of transformed colonies.\",\n      \"method\": \"CIZ1-null mouse fibroblasts, ChIP/immunofluorescence (H4K20me1), nuclear morphology imaging, SET8 manipulation, CIZ1 re-expression rescue, quiescence cycling assay, transformation assay\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — null cells with chromatin mark analysis, rescue experiment, and functional transformation readout; single lab, multiple methods\",\n      \"pmids\": [\"37580709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CIZ1 is released from Xi during prometaphase under regulation of Aurora Kinase B (AURKB). The C-terminal 179/181 amino acids of human/mouse CIZ1 encode a matrin-3 domain that mediates CIZ1 dimerization forming a compact folded core with disordered C-terminal extensions. AURKB phosphorylates three conserved sites in these C-terminal extensions; phosphomimetic mutation at these sites releases CIZ1 from nuclear anchor points and abolishes CIZ1 interaction with RNA (including Xist) without affecting interaction with chromatin or nuclear matrix proteins.\",\n      \"method\": \"Mass spectrometry (56 interacting partners of C-terminal fragment), phosphomimetic and deletion mutagenesis, immunofluorescence (prometaphase CIZ1 release), RNA immunoprecipitation, AURKB inhibitor treatment\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structure-informed mutagenesis of specific AURKB sites, MS-defined interactome, RNA-IP validation, and cell biological demonstration; multiple orthogonal methods in one study\",\n      \"pmids\": [\"41626693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CIZ1 C-terminal anchor domain (AD) exerts a dominant-negative effect on CIZ1-Xi assembly reformation after mitosis, leading to abnormal assemblies depleted of H2AK119ub1 and H3K27me3 and loss of Xist focal localization, with consequent genome-wide deregulation of gene expression in a pattern consistent with unscheduled chromatin exposure to modifying enzymes.\",\n      \"method\": \"Ectopic AD expression (dominant-negative model), immunofluorescence (H2AK119ub1, H3K27me3, Xist RNA FISH), transcriptomics, human tumor transcriptome analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative cellular model with histone mark and Xist localization readouts plus transcriptomic validation; single lab\",\n      \"pmids\": [\"40067149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Med12 (a component of the Mediator kinase module with CDK8) is required for CIZ1 recruitment by Xist and H3K27me3 accumulation during initiation of X chromosome inactivation in mouse embryonic stem cells; CDK8 similarly modulates CIZ1 recruitment, placing the Mediator kinase module upstream of CIZ1 in the Xist silencing pathway.\",\n      \"method\": \"Med12 mutation in ESC model of X inactivation, immunofluorescence/RNA FISH for CIZ1 recruitment, CDK8 perturbation, H3K27me3 ChIP\",\n      \"journal\": \"Epigenetics reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in defined ESC model with direct localization and histone mark readouts; single lab\",\n      \"pmids\": [\"41200585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CIZ1 ablation in fibroblasts causes a post-quiescent reduction in G1 length associated with elevated cyclin E1/E2 and A2 expression and enhanced Rb phosphorylation leading to early restriction-point bypass. CIZ1-null cells show deficient cyclin A chromatin binding and require a 2-fold higher CDK activity threshold for initiation of DNA replication, resulting in DNA replication stress in vitro and in vivo. Addition of recombinant CIZ1 reinstates cyclin A chromatin recruitment and restores the normal CDK threshold for initiation of DNA replication, reversing replication stress and increasing replication fork rates.\",\n      \"method\": \"Fucci(CA) live-cell imaging, cell-free DNA replication assay, DNA fiber combing, cyclin E1/E2/A2 expression analysis, Rb phosphorylation assay, recombinant CIZ1 add-back, CIZ1-KO fibroblasts\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cell-free reconstitution with recombinant protein add-back, live imaging, and DNA fiber combing; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2024.09.02.610838\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"CIZ1 is a nuclear matrix-associated protein with two functionally distinct modules: an N-terminal replication domain that cooperates with cyclin E and then cyclin A–CDK2 (sequentially via distinct cyclin-binding motifs) to promote initiation of mammalian DNA replication at licensed origins, and a C-terminal matrin-3/nuclear matrix anchor domain that immobilizes CIZ1 at replication factories and, in female cells, tethers it to large Xist RNA–dependent supramolecular assemblies at the inactive X chromosome; cyclin-A–CDK2 negatively feeds back by phosphorylating CIZ1 at T144/T192/T293 to block further initiation, while AURKB phosphorylates C-terminal extensions in mitosis to dissolve CIZ1–RNA assemblies; CIZ1 also binds p21(Cip1/Waf1), ERH, CDC6, TCF4, YAP, and DHX9 to coordinate cell-cycle progression, epigenetic maintenance (H2AK119ub1, H3K27me3, H4K20me1), and Xist-mediated gene silencing.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CIZ1 is a nuclear matrix-associated protein that couples cell-cycle-regulated DNA replication initiation to the spatial organization and epigenetic maintenance of chromatin [#2, #4]. Through an N-terminal replication domain it cooperates with cyclin E and then cyclin A\\u2013CDK2 \\u2014 which it engages sequentially via distinct cyclin-binding motifs, cyclin A displacing cyclin E \\u2014 to promote initiation of mammalian DNA replication at licensed origins, immobilizing cyclin-A kinase at subnuclear sites; depletion blocks S-phase entry despite chromatin loading of MCM and PCNA [#2, #8]. Cyclin-A\\u2013CDK2 then provides negative feedback by phosphorylating CIZ1 at threonines 144/192/293, which disrupts the CIZ1\\u2013cyclin-A\\u2013CDK2 interaction and blocks further initiation while preserving nuclear-matrix and CDC6 binding [#12]. A C-terminal matrin-3 anchor domain mediates CIZ1 dimerization and immobilizes the protein at replication factories, and the same anchor tethers CIZ1 to the inactive X chromosome through direct, Repeat-E\\u2013dependent binding to Xist RNA, where it is required for focal Xist localization, transient S-phase repositioning of Xi, and Polycomb-mediated deposition of H2AK119ub1 and H3K27me3 [#4, #15, #16, #17, #22]. Glutamine-rich prion-like domains drive CIZ1 self-assembly into fibrillar networks that build these supramolecular Xi assemblies, and Aurora kinase B phosphorylates the disordered C-terminal extensions in mitosis to release CIZ1 from RNA and dissolve the assemblies [#19, #22]. CIZ1 additionally controls the H4K20me1-dependent nuclear condensation that accompanies quiescence entry, and loss of CIZ1 causes replication stress, restriction-point bypass, and tumor-suppressor failure: CIZ1-null mice develop leukemias and a female-specific lymphoproliferative disorder [#11, #15, #21]. A CIZ1 missense mutation that alters its splicing and nuclear localization is causal for adult-onset primary cervical dystonia [#9]. Beyond its replication and chromatin roles, CIZ1 binds p21(Cip1/Waf1) and regulates its localization, and engages ERH, DHX9, TCF4, and YAP to modulate cell-cycle progression and transcriptional signaling [#0, #5, #18, #20].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the first molecular handle on CIZ1 by showing it binds the CDK2-interacting region of the CDK inhibitor p21 and controls p21 subcellular localization, placing CIZ1 at the cell-cycle machinery.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP and immunofluorescence in U2-OS cells\",\n      \"pmids\": [\"10529385\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Functional consequence for cell-cycle progression not tested\", \"Did not address whether p21 binding competes with other CIZ1 partners\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Asked whether CIZ1 contacts DNA directly and defined a consensus binding sequence, indicating a chromatin-associated rather than purely protein-scaffolding role.\",\n      \"evidence\": \"SAAB sequence selection and EMSA, with nuclear immunofluorescence across tissues\",\n      \"pmids\": [\"12824700\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Genomic targets of the consensus in vivo not identified\", \"Link between DNA binding and replication function not established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined CIZ1's core function as a positive regulator of mammalian DNA replication initiation acting downstream of origin licensing, the keystone mechanistic finding.\",\n      \"evidence\": \"Cell-free replication reconstitution with recombinant protein, GFP overexpression, CDK-site mutagenesis, RNAi with BrdU and chromatin-bound MCM3/PCNA analysis\",\n      \"pmids\": [\"15585571\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Identity of the cyclin/CDK partner driving initiation not yet defined\", \"Did not resolve how CIZ1 is positioned at origins\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved how CIZ1 is spatially organized, mapping a C-terminal nuclear-matrix anchor (aa 708\\u2013830) that immobilizes CIZ1 at replication factories in a cell-cycle-dependent manner, while N-terminal domains specify focal patterning.\",\n      \"evidence\": \"GFP-fragment domain mapping, nuclear matrix fractionation, co-localization with BrdU replication sites\",\n      \"pmids\": [\"17182902\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Molecular nature of the matrix attachment partner not defined\", \"How anchoring is timed to late G1/early S not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed that splice variants and partner recruitment shape CIZ1 function: a cancer-associated \\u0394E4 isoform separates replication activity from foci formation and acts dominant-negatively, and CIZ1 recruits ERH to replication foci through a region overlapping the p21 site.\",\n      \"evidence\": \"Exon-trap splicing assay and dominant-negative coexpression (\\u0394E4); yeast two-hybrid, GST pull-down and MS (ERH)\",\n      \"pmids\": [\"17508423\", \"18081865\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Functional role of ERH recruitment at replication foci untested\", \"Whether p21 and ERH binding are mutually exclusive in vivo not shown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Refined the matrix-association determinant to a 28-residue glutamine-rich element encoded by exon 8, linking alternative splicing of this region to CIZ1 foci formation.\",\n      \"evidence\": \"Immunofluorescence, nuclear matrix fractionation and deletion analysis in transfected cells\",\n      \"pmids\": [\"18583151\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Did not connect the Q-rich element to later-defined prion-like self-assembly\", \"Physiological regulation of exon 8 splicing not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified the cyclin partners and the mechanism of initiation, showing CIZ1 binds cyclin E then cyclin A through distinct motifs and immobilizes cyclin-A\\u2013CDK2 at subnuclear sites to drive replication.\",\n      \"evidence\": \"Cell-free reconstitution with recombinant cyclin-A\\u2013CDK2 and CIZ1, co-IP cyclin displacement, RNAi with cyclin A localization imaging\",\n      \"pmids\": [\"20215406\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How the sequential cyclin switch is temporally controlled not resolved\", \"Origin specificity of CIZ1-targeted cyclin A not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended CIZ1 function beyond somatic replication, linking it to germ-cell cyclin A1 and DSB repair, and identifying a causal dystonia mutation that alters CIZ1 splicing and localization.\",\n      \"evidence\": \"Co-IP and in vitro plasmid repair assay in testis extract; exome sequencing and minigene splicing assay (S264G)\",\n      \"pmids\": [\"22366453\", \"22447717\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct repair substrate and mechanism for CIZ1 in germ cells not defined\", \"How the dystonia mutation produces neuronal pathology not established\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established CIZ1 as a bona fide tumor suppressor in vivo, with null cells sensitive to replication stress and prone to transformation and null mice developing leukemias.\",\n      \"evidence\": \"CIZ1-knockout mice, hydroxyurea sensitivity, oncogene transformation in MEFs, retroviral insertional mutagenesis\",\n      \"pmids\": [\"23583447\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanistic link between replication-stress sensitivity and tumorigenesis not fully resolved\", \"Tissue specificity of tumor spectrum unexplained\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined a negative feedback loop in which cyclin-A\\u2013CDK2 phosphorylates CIZ1 at T144/T192/T293 to terminate further initiation while sparing matrix and CDC6 binding.\",\n      \"evidence\": \"Phosphomimetic mutagenesis, cell-free and cell-based replication assays, co-IP, phospho-T192 antibody, immunofluorescence\",\n      \"pmids\": [\"25736292\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Phosphatase that resets CIZ1 not identified\", \"How feedback restricts initiation to once-per-cycle not fully mechanistic\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed a distinct CIZ1 role at the inactive X chromosome, showing its C-terminal anchor binds Repeat E of Xist RNA to retain Xist focally and maintain H3K27me3, establishing CIZ1 as an Xist-tethering factor.\",\n      \"evidence\": \"CIZ1-null mice with rescue, RNA FISH, STORM single-molecule imaging, reciprocal CIZ1/Repeat-E deletions, H3K27me3 ChIP\",\n      \"pmids\": [\"28546514\", \"28923964\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How RNA binding and matrix anchoring are coordinated not resolved\", \"Whether the same anchor mediates both replication and Xi roles unresolved at this stage\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected CIZ1's replication and Xi functions by showing CIZ1 is required for S-phase repositioning of Xi and for stable PRC1/PRC2 deposition (H2AK119ub1, H3K27me3) and EZH2 retention.\",\n      \"evidence\": \"Live imaging and immunofluorescence of Xi position, CIZ1-null MEFs, histone-mark ChIP, EZH2 fractionation, transcriptomics\",\n      \"pmids\": [\"30692537\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct link between Xi repositioning and PRC retention mechanistically unproven\", \"How replication timing intersects with CIZ1-Xi assembly unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Added a nucleolar dimension, identifying DHX9 as a CIZ1 partner whose RNA Pol I\\u2013dependent co-localization supports G1-to-S progression.\",\n      \"evidence\": \"Molecular panning/MS, in vitro binding, co-localization with Pol I inhibition, siRNA with cell-cycle analysis\",\n      \"pmids\": [\"33093612\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism by which CIZ1\\u2013DHX9 promotes S-phase entry not defined\", \"Single-lab in vitro interaction without reciprocal in vivo validation\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided the structural and biophysical basis for CIZ1 assembly, defining two independent Xist-binding domains, two glutamine-rich prion-like domains driving fibrillar self-assembly, and the atomic ERH\\u2013CIZ1 heterotetramer interface.\",\n      \"evidence\": \"RNA-IP domain mapping, in vitro self-assembly assays and rescue in null cells (PLDs); crystal structure with interface mutagenesis (ERH)\",\n      \"pmids\": [\"35289833\", \"36047590\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Functional role of ERH binding in replication or Xi assembly not established\", \"How PLD-driven self-assembly is regulated in cells not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Linked CIZ1 to quiescence by showing it sustains H4K20me1 needed for nuclear condensation, and that repeated quiescence cycling without CIZ1 drives genome instability and transformation.\",\n      \"evidence\": \"CIZ1-null fibroblasts, H4K20me1 ChIP/IF, nuclear morphology imaging, SET8 manipulation, rescue and quiescence cycling/transformation assays\",\n      \"pmids\": [\"37580709\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How CIZ1 supports SET8-dependent H4K20me1 mechanistically unknown\", \"Causal chain from condensation defect to transformation not fully established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined the mitotic regulation and structural architecture of the CIZ1 anchor, showing the matrin-3 domain dimerizes into a folded core with disordered extensions that AURKB phosphorylates to release CIZ1 from RNA and Xi during prometaphase, and that the anchor domain acts dominant-negatively to disrupt post-mitotic Xi reassembly and Polycomb marks.\",\n      \"evidence\": \"MS interactome, structure-informed phosphomimetic/deletion mutagenesis, RNA-IP, AURKB inhibition, prometaphase imaging; ectopic anchor-domain dominant-negative model with histone-mark/Xist FISH and tumor transcriptomics\",\n      \"pmids\": [\"41626693\", \"40067149\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"How AURKB phosphorylation is reversed to permit reassembly not resolved\", \"Whether mitotic release is selectively used at Xi versus replication factories unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Placed CIZ1 within an upstream regulatory pathway by showing the Mediator kinase module (Med12/CDK8) is required for Xist-directed CIZ1 recruitment and H3K27me3 accumulation at the onset of X inactivation.\",\n      \"evidence\": \"Med12 mutation and CDK8 perturbation in an ESC X-inactivation model with CIZ1 recruitment imaging and H3K27me3 ChIP\",\n      \"pmids\": [\"41200585\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether Mediator kinase acts directly on CIZ1 or via intermediates unknown\", \"Single-lab genetic epistasis without biochemical mechanism\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CIZ1's replication-initiation activity and Xist-tethering activity are mechanistically integrated through a shared anchor and self-assembly machinery, and what resets the system between cell cycles, remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No phosphatase or reset mechanism for cyclin-A or AURKB phosphorylation identified\", \"Direct structural model of CIZ1 at an origin versus at Xi not resolved\", \"Mechanism linking transcriptional coactivator roles (YAP/TCF4/ER\\u03b1) to the matrix/replication functions undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [16, 19, 22]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [4, 22]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [8, 12]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 8]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 13, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [15, 16, 17]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [4, 15]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [2, 8, 12]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [8, 12, 25]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [16, 17, 21, 23]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [16, 17, 23]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 9]}\n    ],\n    \"complexes\": [\n      \"CIZ1\\u2013Xist RNA assembly at inactive X chromosome\",\n      \"ERH\\u2013CIZ1 2:2 heterotetramer\"\n    ],\n    \"partners\": [\n      \"CCNA2\",\n      \"CCNE1\",\n      \"CDK2\",\n      \"CDKN1A\",\n      \"ERH\",\n      \"DHX9\",\n      \"CDC6\",\n      \"YAP1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":8,"faith_total":8,"faith_pct":100.0}}